Sign Up to like & get
recommendations!
1
Published in 2019 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2018-203
Abstract: Targeting BCMA with the antibody-drug conjugate GSK2857916 is well tolerated in a phase I trial.
read more here.
Keywords:
targeting bcma;
bcma achieves;
responses multiple;
durable responses ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15082240
Abstract: Simple Summary Despite the variety of drugs used to treat multiple myeloma and the ever-lengthening survival times, a recurring problem is that many current drugs affect healthy cells, causing side effects, additional illnesses, and drug…
read more here.
Keywords:
plasma cells;
myeloma;
targeting bcma;
multiple myeloma ... See more keywords